Search Results
Found 1 results
510(k) Data Aggregation
(90 days)
The ZEUS IFA™ nDNA Test System is an indirect immunofluorescence assay utilizing Crithidia luciliae for the qualitative and semi-quantitative determination of anti-native DNA (nDNA) IgG antibodies to DNA in human serum by manual fluorescence microscopy or with ZEUS dIFine®. The presence of nDNA antibodies in conjunction with other serological and clinical findings can be used to aid in the diagnosis of systemic lupus erythematosus (SLE).
Not Found
This document is an FDA clearance letter for the ZEUS IFA nDNA Test System. It does not contain information about the acceptance criteria or a study proving the device meets those criteria. The provided text is a standard FDA 510(k) clearance letter, confirming the device's substantial equivalence to a predicate device and outlining regulatory obligations.
Therefore, I cannot provide the requested information based on the provided input. The details about acceptance criteria, study design, sample sizes, expert involvement, and ground truth establishment are not present in this regulatory document.
Ask a specific question about this device
Page 1 of 1